TBPH — Theravance Biopharma Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Theravance Biopharma Inc (TBPH), worth $159.56M combined. Over the quarter 2 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Madison Avenue | $156.61M | 6.70% | -3.1% |
| Renaissance | $2.62M | 0.00% | +20.6% |
| Quadrature | $331.40K | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.